Author

Yubai Zhou

University of North Carolina at Chapel HillORCID 0000-0003-3704-283XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yubai Zhou1 paper · University of North Carolina at Chapel Hill

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Desmarini DesmariniiD· 1 shared Dilipkumar UrediiD· 1 shared Hundaol Huluka· 1 shared Julianne T. DjordjeviciD· 1 shared Lucia E. RamehiD· 1 shared Michael A. Stashko· 1 shared Pratima Chapagain· 1 shared Raymond D. BlindiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Desmarini DesmariniORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyJournal of Medicinal ChemistryPeer-reviewedJul 25, 2025

Design, synthesis and cellular characterization of a new class of IPMK kinase inhibitors

Yubai Zhou, Pratima Chapagain, Desmarini Desmarini…·Xiaodong Wang

This study designs, synthesizes, and characterizes a new class of IPMK kinase inhibitors, showing reduced glioblastoma cell growth and a novel InsP5 metabolic signature.

7 citations

humanexperimental assay

𝕏 PostBluesky